BridgeMD
New treatment option for Ankylosing Spondylitis
Official title The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis
ClinicalTrials.gov ID: NCT07166874
What this study is testing
- What it's testing
- Subclinical intestinal inflammation and intestinal permeability have been reported in patients with ankylosing spondylitis. Gluten is one of the main triggers of zonulin releaseand gluten intake may contribute to the development of the disease by increasing intestinal permeability.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- diagnosis of axial SpA defined by ASAS criteria
- Adults (aged 18-64 years)
- stable treatment (NSAID and/or DMARD) for at least 3 months
- provide written informed consent and submit to the requirements of the study
You likely can't join if
- Any diet at the time of inclusion or within 3 months prior to inclusion;
- have a history of celiac disease;
- have a history of Ulcerative Colitis, Crohn's Disease and Irritable Bowel Syndrom
- patients with Type 1 and Type 2 Diabetes Mellitus
- patients with Hashimoto Thyroiditis
- are pregnant, breastfeeding,
See the full eligibility criteria
- diagnosis of axial SpA defined by ASAS criteria
- Adults (aged 18-64 years)
- stable treatment (NSAID and/or DMARD) for at least 3 months
- provide written informed consent and submit to the requirements of the study
- Any diet at the time of inclusion or within 3 months prior to inclusion;
- have a history of celiac disease;
- have a history of Ulcerative Colitis, Crohn's Disease and Irritable Bowel Syndrom
- patients with Type 1 and Type 2 Diabetes Mellitus
- patients with Hashimoto Thyroiditis
- are pregnant, breastfeeding,
- patients who have used omega-3 and vitamins (A, C, E) regularly in the last 3 months.
- BMI \<18,50 kg/m2
- BMI ≥29,99 kg/m2
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.